SCHEMBL2170387

SCHEMBL2170387

CC1CCN(CC(=O)NC(C)(C(N)=O)c2ccc(Oc3ccc(F)cc3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
RECQL P46063 1/20 0.41
TSHR P16473 1/20 0.41
SCN9A Q15858 3/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
HTT P42858 1/20 0.40
KCNT1 Q5JUK3 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CHRM2 P08172 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
DRD1 P21728 1/20 0.39
ADRA1A P35348 1/20 0.39
OPRM1 P35372 1/20 0.39
DRD3 P35462 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2173692 0.88 HRH3 (0.41) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL2171837 0.87 ALDH1A1 (0.52) ALDH1A1KDM4ETSHRSCN9AMEN1
SCHEMBL2171604 0.87 SCN9A (0.44) ALDH1A1KDM4ESMN1; SMN2SCN9AMEN1
SCHEMBL2169794 0.87 ALDH1A1 (0.45) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL2170422 0.83 ALDH1A1 (0.39) ALDH1A1KDM4ESMN1; SMN2SCN9AMEN1
SCHEMBL2172986 0.82 ALDH1A1 (0.40) ALDH1A1KDM4ESMN1; SMN2RECQLMEN1
SCHEMBL2170251 0.80 ALDH1A1 (0.57) ALDH1A1KDM4ESMN1; SMN2TSHRMEN1
SCHEMBL2350975 0.77 TRPV1 (0.50) ALDH1A1
SCHEMBL2170398 0.75 ALDH1A1 (0.51) ALDH1A1KDM4ETDP1SMN1; SMN2RECQL
SCHEMBL2171613 0.74 EPHX2 (0.51) ALDH1A1KDM4ESMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346821-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS Exelixis, Inc. (US) 2011-07-27 EP disclosed